Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 16, 2026
Northrop Grumman (NOC) Stock Advances +12.3% in 30 Days on Strong Q2 Results and Record Backlog

Northrop Grumman (NOC) Stock Advances +12.3% in 30 Days on Strong Q2 Results and Record Backlog

Key Takeaways

  • Northrop Grumman shares rose approximately 12.3% over the 30 days ending in mid-August 2026, from a July 17 close of $521.57 to $585.87.
  • The advance followed stronger-than-expected Q2 2026 results, raised full-year guidance, a record backlog, and new multi-year missile-defense framework agreements.
  • Shares briefly touched a 52-week low of $479.02 on July 21 before reversing higher, underscoring the volatility around the earnings release.
  • Over the trailing three months, NOC is up about 8.4%, reflecting a recovery from a late-June pullback and sustained defense-sector demand.
  • Key watch items include third-quarter results expected in late October, B-21 and Sentinel program execution, and conversion of missile-defense demand into revenue.

Northrop Grumman (NOC) Company Overview

Northrop Grumman operates as a diversified aerospace and defense technology company through four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Its portfolio includes the B-21 Raider bomber, Global Hawk autonomous aircraft, F-35 fuselage work, tactical and strategic missiles, missile defense systems, advanced radar and electronic warfare capabilities, satellites, and solid rocket motors. As a prime contractor on long-cycle programs such as B-21 and Sentinel, and a key supplier in national security space and rocket propulsion, Northrop remains closely followed for its exposure to defense budgets, backlog visibility, and execution on classified and international programs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Northrop Grumman (NOC) Stock Price Performance Over the Last 30 Days and Quarter

Over the last 30 days, NOC climbed from $521.57 on July 17, 2026, to $585.87 at the most recent completed close on Aug. 14, 2026 — a gain of about 12.3%. The path was volatile: shares opened sharply lower on the July 21 earnings session, dipped to $479.02 intraday, and closed at $512.29 before staging a steady multi-week recovery. From that earnings-day close, the stock added roughly 14% through mid-August.

Measured over the trailing three months, the move is more moderate. From the nearest trading session three months earlier, when shares closed at $540.69, NOC advanced about 8.4%. The quarter was choppy, however, with a late-May-to-June slide to $496.02 on June 29 followed by the earnings-driven rebound. Even after the rally, NOC remained below its 52-week high of $774.00.

What Drove NOC Stock Price in the Last 30 Days

The most important catalyst was the July 21 Q2 2026 report. Northrop earned $7.68 per share, beating the $6.82 consensus estimate, while revenue rose 5.1% year over year to $10.88 billion, above the roughly $10.80 billion analysts expected. Management raised full-year sales guidance to $43.75 billion–$44.25 billion and lifted adjusted EPS guidance to $28.60–$29.10, while reaffirming adjusted free cash flow of $3.1 billion–$3.5 billion. Net awards of $20 billion pushed total backlog to a record $105 billion, up 17% from a year earlier, with a second-quarter book-to-bill of 1.84x.

Initially, margin concerns tempered the reaction. Defense Systems and Space margins were pressured by unfavorable cost adjustments on the GEM 63XL rocket motor and the Stand-in Attack Weapon program, and shares briefly hit a 52-week low before recovering. The rally then broadened in early August after Northrop announced more than $3 billion in multi-year framework agreements with the U.S. Department of War and Lockheed Martin (LMT) to accelerate PAC-3 MSE and THAAD component production. Combined with broader aerospace-and-defense strength tied to missile-defense demand, those catalysts carried the stock above $585 by mid-August.

What Drove NOC Stock Performance Over the Last Quarter

The broader multi-month trend was defined by a spring-to-summer reset followed by a demand-driven rebound. From the $540 area in mid-May, shares slid through June to $496.02 on June 29 as investors weighed defense-budget uncertainty and near-term program-margin pressures. Sentiment shifted with the Q2 earnings beat and record backlog, which reinforced the company's multi-year demand visibility. The early-August missile-defense framework agreements then extended the recovery, leaving NOC about 8.4% higher over the trailing three months while still below its prior 52-week peak.

NOC Stock Forecast Drivers: What Investors Should Watch Next

Investors will likely focus on third-quarter results, which are expected in late October based on Northrop's typical reporting schedule. Key items include execution against the raised full-year sales and EPS guidance, second-half margin recovery in Space and Defense Systems, and progress on the B-21 Raider production acceleration agreement and Sentinel program milestones. The anticipated PAC-3 MSE production award later in 2026, further missile-defense orders, and the pace of international sales growth may also influence sentiment. Macro factors such as the U.S. defense budget process, global security spending, and cost pressures on fixed-price development programs remain important risks to monitor. From what I see, these elements will be critical for sustaining the recent momentum.

AI Tools for Tracking Defense Stocks

In my analysis, I frequently review Tickeron’s Trending AI Robots page to identify automated strategies that align with current market conditions in sectors like defense. The page curates top-performing bots from a wider set of hundreds of strategies, allowing traders to filter by style, timeframe, and performance metrics. This serves as a useful discovery tool when evaluating systematic approaches to stocks such as NOC.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NOC

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


NOC in upward trend: 10-day moving average moved above 50-day moving average on August 03, 2026

The 10-day moving average for NOC crossed bullishly above the 50-day moving average on August 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2026. You may want to consider a long position or call options on NOC as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NOC just turned positive on July 23, 2026. Looking at past instances where NOC's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

NOC moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NOC advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NOC entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NOC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.653) is normal, around the industry mean (10.074). P/E Ratio (18.623) is within average values for comparable stocks, (90.575). Projected Growth (PEG Ratio) (4.046) is also within normal values, averaging (8.189). Dividend Yield (0.016) settles around the average of (0.016) among similar stocks. P/S Ratio (1.950) is also within normal values, averaging (25.772).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.1B. The market cap for tickers in the group ranges from 4.49 to 1.85T. SPCX holds the highest valuation in this group at 1.85T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 3%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 8%. DFSC experienced the highest price growth at 138%, while EVTL experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 71%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 65
Price Growth Rating: 50
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
NOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of innovative systems, products and solutions in aerospace, electronics and information systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
2980 Fairview Park Drive
Phone
+1 703 280-2900
Employees
101000
Web
https://www.northropgrumman.com
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.